CLINICAL_TRIALS
trial_result
· 2018-11-15
Clinical Trial Update: SIMBRINZA® Suspension BID as an Adjunctive to Prostaglandin Analogue (PGA) [Phase 4]
Summary
Phase 4 trial updating SIMBRINZA suspension as adjunctive therapy to prostaglandin analogues in open-angle glaucoma or ocular hypertension; study completed with…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alcon Research | Conditions: Open-Angle Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2018-11-15